6533b833fe1ef96bd129b91b

RESEARCH PRODUCT

Dairy consumption, plasma metabolites, and risk of type 2 diabetes.

Alberto AscherioAlberto AscherioLorelei A. MucciLorelei A. MucciLiming LiangDeirdre K TobiasDeirdre K TobiasClemens WittenbecherMiguel A. Martínez‐gonzálezMiguel ÁNgel Martínez-gonzálezMiguel ÁNgel Martínez-gonzálezMontserrat FitóKathryn M. RexrodeCharles S. FuchsMarta Guasch-ferréMarta Guasch-ferréRamon EstruchRamon EstruchDolores CorellaDolores CorellaJun LiPablo Hernández-alonsoElizabeth W. KarlsonJordi Salas-salvadóCourtney DennisKaren H. CostenbaderMiguel Ruiz-canelaMiguel Ruiz-canelaClary B. ClishCristina RazquinCristina RazquinJean-philippe Drouin-chartierJean-philippe Drouin-chartierEstefanía ToledoEstefanía ToledoA. Heather EliassenA. Heather EliassenFrank B. HuFrank B. Hu

subject

0301 basic medicineMalemedicine.medical_specialtyMetabolitePopulationMedicine (miscellaneous)Type 2 diabetes030204 cardiovascular system & hematologycheeseCohort Studiesyogurt03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsInternal medicineMedicineAnimalsHumansProspective StudieseducationProspective cohort studyDieta mediterraneaAgedmilkprospective cohort studyeducation.field_of_studyNutrition and DieteticsHealth professionalsbusiness.industryEditorialsFeeding BehaviorMiddle Agedmedicine.diseasemetabolomicsPredimed030104 developmental biologyMilkchemistryDiabetes Mellitus Type 2CohortdairyFemaletype 2 diabetesDairy Productsbusiness

description

Background Epidemiologic studies have reported a modest inverse association between dairy consumption and the risk of type 2 diabetes (T2D). Whether plasma metabolite profiles associated with dairy consumption reflect this relationship remains unknown. Objectives We aimed to identify the plasma metabolites associated with total and specific dairy consumption, and to evaluate the association between the identified multi-metabolite profiles and T2D. Methods The discovery population included 1833 participants from the Prevencion con Dieta Mediterranea (PREDIMED) trial. The confirmatory cohorts included 1522 PREDIMED participants at year 1 of the trial and 4932 participants from the Nurses' Health Studies (NHS), Nurses' Health Study II (NHSII), and Health Professionals Follow-Up Study US-based cohorts. Dairy consumption was assessed using validated FFQs. Plasma metabolites (n = 385) were profiled using LC-MS. We identified the dairy-related metabolite profiles using elastic net regularized regressions with a 10-fold cross-validation procedure. We evaluated the associations between the metabolite profiles and incident T2D in the discovery and the confirmatory cohorts. Results Total dairy intake was associated with 38 metabolites. C14:0 sphingomyelin (positive coefficient), C34:0 phosphatidylethanolamine (positive coefficient), and γ-butyrobetaine (negative coefficient) were associated in a directionally similar fashion with total and specific (milk, yogurt, cheese) dairy consumption. The Pearson correlation coefficients between self-reported total dairy intake and predicted total dairy intake based on the corresponding multi-metabolite profile were 0.37 (95% CI, 0.33-0.40) in the discovery cohort and 0.16 (95% CI, 0.13-0.19) in the US confirmatory cohort. After adjusting for T2D risk factors, a higher total dairy intake-related metabolite profile score was associated with a lower T2D risk [HR per 1 SD; discovery cohort: 0.76 (95% CI, 0.63-0.90); US confirmatory cohort: 0.88 (95% CI, 0.78-0.99)]. Conclusions Total dairy intake was associated with 38 metabolites, including 3 consistently associated with dairy subtypes (C14:0 sphingomyelin, C34:0 phosphatidylethanolamine, γ-butyrobetaine). A score based on the 38 identified metabolites showed an inverse association with T2D risk in Spanish and US populations.

10.1093/ajcn/nqab047https://pubmed.ncbi.nlm.nih.gov/33963729